Article
TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN
1 Mar 2023
Abstract excerpt
Abstract We report herein that TSPAN32 is a key node factor for Philadelphia (Ph+) leukemia pathogenesis. We found that TSPAN32 expression was repressed by BCR-ABL and ectopic TSPAN32 expression upon Imatinib treatment inhibited the proliferation of Ph+ cell lines. Tspan32 overexpression significantly prevented BCR-ABL induced leukemia progression in a murine model and impaired leukemia stem cell (LSC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
